Ironwood Pharmaceuticals (IRWD) Interest & Investment Income (2010 - 2026)

Ironwood Pharmaceuticals (IRWD) has 17 years of Interest & Investment Income data on file, last reported at $1.7 million in Q1 2026.

• For the quarter ending Q1 2026, Interest & Investment Income rose 95.4% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $4.9 million (up 17.68% YoY), and the FY2025 full-year result was $4.1 million, down 8.77% from the prior year.
• Interest & Investment Income grew to $1.7 million in Q1 2026, from $1.5 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $8.8 million in Q2 2023 to a low of $230000.0 in Q1 2022.
• A 5-year average of $2.3 million and a median of $1.2 million in 2023 frame the typical range for Interest & Investment Income.
• Across the five-year window, Interest & Investment Income jumped 3061.74% in 2023 and plunged 84.37% in 2024, its largest moves.
• Tracing IRWD's Interest & Investment Income over 5 years: stood at $5.4 million in 2022, then plunged by 78.08% to $1.2 million in 2023, then plunged by 34.84% to $778000.0 in 2024, then surged by 87.53% to $1.5 million in 2025, then rose by 16.38% to $1.7 million in 2026.
• Business Quant data shows IRWD's Interest & Investment Income at $1.7 million in Q1 2026, $1.5 million in Q4 2025, and $930000.0 in Q3 2025.